INAB: IN8bio, Inc. Stock

by  •  • Comments Off on INAB: IN8bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 20.73
Enterprise Value ($M) 16.73
Book Value ($M) 8.59
Book Value / Share 0.12
Price / Book 2.41
NCAV ($M) -0.68
NCAV / Share -0.01
Price / NCAV -30.71

Profitability (mra)
Return on Invested Capital (ROIC) -2.27
Return on Assets (ROA) -0.95
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 1.84
Current Ratio 1.84

Balance Sheet (mrq) ($M)
Current Assets 6.70
Assets 15.97
Liabilities 7.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-11 13D/A BIOS Fund II, LP 23.10 0.00
10-09 13G Hirschman Orin 9.30 188.60
02-13 13G/A Ho William Tai-Wei 7.10 7.78

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 87,696 694,950 12.62
2025-01-21 74,316 432,383 17.19
2025-01-17 107,489 377,129 28.50

(click for more detail)

Similar Companies
HROW – Harrow, Inc. IKNA – Ikena Oncology, Inc.
IMRX – Immuneering Corporation IOVA – Iovance Biotherapeutics, Inc.
IPA – ImmunoPrecise Antibodies Ltd.


Financial data and stock pages provided by
Fintel.io